Omega-3 Fatty Acid Supplement to OROS-Methylphenidate Pharmacotherapy in Attention Deficit Hyperactivity Disorder (ADHD) Adults With Deficient Emotional Self-Regulation (DESR) Traits
This study is currently recruiting participants.
Verified May 2013 by Massachusetts General Hospital
Sponsor:
Massachusetts General Hospital
Information provided by (Responsible Party):
Craig B. Surman, MD, Massachusetts General Hospital
ClinicalTrials.gov Identifier:
NCT01399827
First received: July 20, 2011
Last updated: May 10, 2013
Last verified: May 2013
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study is currently recruiting participants. |
|---|---|
| Estimated Study Completion Date: | November 2014 |
| Estimated Primary Completion Date: | September 2014 (Final data collection date for primary outcome measure) |